劲仔食品（003000）：经营表现承压，期待H2改善

Investment Rating - The report maintains a "Strong Buy" rating for the company [2][6] Core Views - The company's Q2 revenue and profit decreased by 10.4% and 36.3% year-on-year, respectively, due to weak demand, intensified competition, and product adjustments, leading to a challenging operational performance [6] - For H2, the company aims to innovate new products in dried fish and bean products, accelerate the offline promotion of its egg brand "Seven Doctors," and enhance the promotion of anchovy products across multiple channels, with expectations for improved revenue and profit margins [6] - The forecast for net profit attributable to the parent company for 2025-2027 is adjusted to 260 million, 300 million, and 350 million, respectively, with corresponding EPS of 0.57, 0.67, and 0.78 yuan, maintaining a 20x PE for 2026 [6] Financial Performance - In H1 2025, the company achieved revenue of 1.124 billion yuan, a slight decrease of 0.5% year-on-year, and a net profit of 112 million yuan, down 21.86% year-on-year [6][7] - The Q2 revenue breakdown shows that fish products, poultry products, bean products, and vegetable products generated revenues of 757 million, 196 million, 115 million, and 34 million yuan, respectively, with year-on-year changes of +7.61%, -24.00%, +3.61%, and -10.69% [6] - The company's gross margin for Q2 was 28.93%, down 1.83 percentage points year-on-year, primarily due to rising raw material prices and low capacity utilization [6] Market Position and Shareholder Information - The total market capitalization of the company is 6 billion yuan, with a circulating market value of 4 billion yuan [2] - The major shareholder, Zhou Jinsong, holds a 38.22% stake in the company [2]